Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a Portuguese hospital

Rogério Ruas; Pedro Palma; Fátima Lamas; Anunciação Ruivo; Rui Malheiro; Rita Ferraz

doi:10.1097/j.pbj.0000000000000239

Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a Portuguese hospital

Porto Biomed J. 2023 Dec 13;8(6):e239. doi: 10.1097/j.pbj.0000000000000239. eCollection 2023 Nov-Dec.

Authors

Rogério Ruas¹, Pedro Palma¹, Fátima Lamas², Anunciação Ruivo², Rui Malheiro³, Rita Ferraz¹

Affiliations

¹ Infectious Diseases Department, Centro Hospitalar Tâmega e Sousa, Penafiel, Portugal.
² Immunohemotherapy Department, Centro Hospitalar Tâmega e Sousa, Penafiel, Portugal.
³ Institut of Public Health of Porto (ISPUP), Porto, Portugal.

Abstract

Background: Health care workers (HCW) are presumably exposed to a higher risk of infection by SARS-CoV-2 and could possibly represent a source of transmission to susceptible patients. Thus, characterization of SARS-CoV-2 infection among HCW is necessary to better understand the determinants of viral transmission and properly implement strategies to prevent dissemination and protect HCW and vulnerable patients. The aim of this study was to estimate the seroprevalence of antibodies against SARS-CoV-2 in a Portuguese tertiary hospital, in the period of July 2020 to March 2021, before the generalized use of the SARS-CoV-2 vaccine, characterize its evolution over time, and identify risk factors associated with seroconversion.

Methods: HCW were approached to collect serum samples for qualitative SARS-CoV-2 antibody testing and completion of an online survey capturing demographics, previous symptoms, and details of health care and community exposure. Odds ratio with bivariable and multivariable logistic regression was used to assess characteristics associated with seroprevalence.

Results: One thousand HCW were included for analysis. Two hundred nineteen HCW (22%) were seropositive for immunoglobulin G against SARS-CoV-2, and 166 (17%) were seropositive for immunoglobulin M, most of whom reported a previous diagnosis of SARS-CoV-2 infection. The risk factors associated with seroconversion included a previous COVID-19 diagnosis, contact with patients, occupational contact with colleagues, and outside contact. However, in a multivariate logistic regression analysis, only a previous diagnosis and outside contact were associated with seroconversion. Seropositivity decreased over time, especially 28 weeks after infection.

Conclusion: HCWs have a high seroprevalence for SARS-CoV-2 infection, probably due to a combination of health care and community exposure. Seropositivity decreases over time, but further studies are needed to better understand our adaptive immune response.

Keywords: SARS-CoV-2; health care workers; seroprevalence.